Market›Health Care›Health Care Providers & Services›Health Care Distributors
SINOPHARM GROUP CO L Class H

SHTDF

$2.30Apr 28, 2021 – Apr 27, 2026
Health CareHealth Care Providers & ServicesHealth Care Distributors$7.18B
MVM
+$7.18B
TD Variance
0.217

Every news event mapped to its market reaction — 25 events, 61 months of data. No predictions, just what happened.

PositiveNegativeNo data· Dot size = magnitude · Scroll to zoom · Drag to pan
Hover to inspect

Want the full written briefing?

The chart shows what moved — the briefing shows why. Sourced, dated, no hot takes.

Subscribe on Substack →

News Events

DateReturnCategorySourceHeadline
2021-05-07+10.4%newsSeeking AlphaSinopharm COVID-19 vaccine wins WHO emergency use nod
2021-05-05-8.1%newsSeeking AlphaWorlds most vaccinated nation reintroduces curbs to counter surge in COVID-19 cases
2023-01-11-6.6%newsSeeking AlphaMerck mulls legal action against unsanctioned distributors of its COVID drug in China
2024-11-21-5.8%earningsSeeking AlphaSinopharm Group: The Focus Is On Working Capital And Profitability
2023-01-20-3.5%newsSeeking AlphaSinopharm unit cleared to study first mRNA COVID shot in China
2021-12-28-3.2%newsSeeking AlphaUAE approves emergency use of Sinopharm's COVID-19 vaccine
2021-09-17-3.1%newsSeeking AlphaSmall study indicates benefit of Sinopharm COVID booster shot
2022-02-07+2.7%newsSeeking AlphaSouth African regulator registers Chinese Sinopharm vaccine, Pfizer/BioNTech's COMIRNATY
2022-07-07+2.4%M&ASeeking AlphaSinopharm mulls $1B acquisition of Shanghai-based BBI Life Sciences - Bloomberg
2025-04-17+2.2%earningsSeeking AlphaSinopharm Group: Mixed Read-Throughs From Peer Disclosures And Management Guidance
2026-03-19+1.9%newsPR NewswireWoori IO, an OSR Company, Signs NDA with Sinopharm for China Market and Global Multicenter Trials
2026-03-19+1.9%newsACCESS NewswireWoori IO, an OSR Company, Signs NDA with Sinopharm to Explore China Commercial Opportunities
2021-06-21-1.6%newsSeeking AlphaChina reaches a milestone in COVID-19 vaccination with 1 billion shots
2022-04-08-1.5%newsSeeking AlphaSupply chain on watch as Shanghai lockdown grows in severity
2021-09-03+1.5%newsSeeking AlphaChina is struggling to expand COVID-19 vaccination drive - official
2023-02-24+1.5%newsSeeking AlphaGE HealthCare and Sinopharm to form joint venture in China
2021-07-12-1.4%newsSeeking AlphaChinese COVID-19 shots have nearly 70% efficacy against Delta variant, scientist says
2021-08-02+1.3%newsSeeking AlphaSinopharm COVID-19 shot offers a lower antibody response against Delta variant - study
2021-06-25+1.2%newsSeeking AlphaSome Chinese vaccines less effective against COVID-19 Delta variant - Reuters
2023-04-13-1.1%newsSeeking AlphaPfizer collaborates with Sinopharm to expand in China
2026-03-21+0.9%newsSimply Wall St.Sinopharm Explores Noninvasive Glucose Monitoring To Deepen China Diabetes Role
2021-05-27-0.8%newsSeeking AlphaSinopharm's two COVID-19 vaccines shows efficacy "more than 70%", study says
2022-10-07+0.5%newsSeeking AlphaU.S. report says COVID vaccines led to over 300K fewer deaths among Medicare beneficiaries
2024-06-03-0.2%analystSeeking AlphaSinopharm Group: External Headwinds And Re-Rating Drivers Draw Attention
2021-10-12-0.1%newsSeeking AlphaWHO recommends an additional COVID-19 vaccine for immunocompromised people
tickerdossier.comtickerdossier.substack.com